National Cancer Center-KAIST Collaborate to Train Cancer Treatment and Medical Science Experts

President Kwang-Hyung Lee of Korea Advanced Institute of Science and Technology (left) and Director Hong-Kwan Seo of the National Cancer Center held a signing ceremony for a mutual cooperation agreement on the 8th and are taking a commemorative photo. (Photo by National Cancer Center)

[Asia Economy Reporter Chunhee Lee] The National Cancer Center and the Korea Advanced Institute of Science and Technology (KAIST) are strengthening their cooperation to develop treatment technologies for intractable cancers and to train medical scientists.

On the 8th, the National Cancer Center announced this at a mutual cooperation agreement ceremony held at the Seoul International Financial Center (IFC Seoul) in Yeongdeungpo-gu, Seoul. Since 2019, the two institutions have been conducting joint research, facility and personnel exchanges in basic and applied fields, as well as future-oriented convergence research fields through agreements. Following the previous agreement, the new agreement expands the scope of cooperation to include ▲ education for nurturing talent in the medical science field ▲ establishment of research infrastructure ▲ research in big data-based artificial intelligence (AI) and digital health technology development, and plans to form a joint committee to promote future cooperation.

Seo Hong-gwan, Director of the National Cancer Center, said, “We aim to strengthen open research cooperation between the two institutions and prioritize the development of healthcare technologies for cancer survivors and the development of an ovarian cancer treatment education system utilizing the metaverse.” He added, “With this agreement, the two leading institutions representing Korea’s medical science field will solidify their cooperative system and lead the development of treatment technologies for intractable cancers in Korea.” KAIST President Lee Kwang-hyung also stated, “We will do our best to expand the cooperative system in various fields such as conducting joint research with the National Cancer Center, opening joint courses and training programs, and establishing research centers, so that medical science innovation in the field of intractable cancers can be achieved.”